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Objectives 
Lyme borreliosis is the most prevalent tick-borne infection in the northern hemisphere affecting both humans 
and animals including horses. The complex interactions between the pathogen, Borrelia burgdorferi spp , the 
vector, mainly Ixodes ricinus in Europe and the widespread range of hosts, as well as the impact of several 
climatic and non-climatic factors affecting these interactions support the necessity of interdisciplinary 
collaboration for surveillance and prevention. Because humans and horses commonly share the same habitat the 
epidemiological data collected in horses can be potentially useful for assessing risk factors for human borreliosis. 
Unfortunately, the lack of specific symptoms in horses makes diagnosis a challenging task for veterinarians. 
Antibody testing is for these reasons a valuable tool but must be interpreted with caution. 
The objective of our study was to provide accurate data concerning the prevalence of Borrelia burgdorferi sensu 
lato antibodies in horses living in the Southern part of Belgium as well as to assess diagnostic value of the 
commonly used serological tests (IF and ELISA) in order to promote critical interpretation of positive test 
results. An invalid diagnosis of Lyme disease will indeed have negative consequences for the horse as well as for 
public health regarding to the threat this represents for antibiotic resistance. By arguing for an adapted use and 
interpretation of serologic tests we intended to promote rational use of antibiotics. 
Methods 
To achieve our objective we conducted three complementary studies. We conducted a prevalence study on a 
sample of 303 serums collected between April 2014 and April 2016 from horses living in Wallonia who hadn't 
presented any clinical symptom suggestive of Lyme disease in the past 12 months. Secondly we assessed the 
diagnostic value of the two most commonly used serologic tests ELISA and IF, by comparing the test results of 
100 serums with the results of a western blot test, used for the purpose as reference standard. In the third part we 
evaluated the impact of 4 different diagnostic strategies and evaluated the outcome with emphasize on 
preventing unnecessary use of antibiotics (cost-benefit analysis). 
Results 
A seroprevalence of 22% was observed in our sample with an evidence of age related effect (p-value=0.02) on 
the presence of Borrelia burgdorferi antibodies. When evaluating diagnostic value of serological tests we could 
observe that IF and ELISA tests both perform well regarding to sensitivity and are adapted tests when used as 
first step testing. Their specificity is too low to be able to be confident in the positive testresultsand so ELISA 
and IF are not adapted to be used alone  to confirm Lyme disease in horses. A second more specific test (western 
blot) is necessary to confirm the positive results. With regard to rational use of antibiotics we could observe a 
possible decrease ranging from 17 to 47% of non-appropriate antibiotic use when choosing for a two-step 
strategy compared to the use of a single serology. 
 
Conclusion 
This study argues for a necessary change in the management of horses suspected of Lyme disease. Taking in 
account the epidemiologic datas of seroprevalence in Wallonia, as well as the diagnostic values of the two most 
commonly used serologic tests we illustrated the urgent need to convince veterinary practitioners to confirm the 
positive results of Borrelia burgdorferi before administration of antibiotic treatment. 
This study on Lyme disease is thus an example of a “one health” driven study. 
 
